PA-BOOMI
Boomi™, the intelligent integration and automation leader, is thrilled to announce Boomi World is back. The company’s highly anticipated industry event will take place May 6-9, 2024 at the Sheraton Denver Downtown Hotel in Denver, Colorado. Boomi World 2024 promises to be a transformative experience, bringing together industry leaders, technology experts, and visionary professionals to explore the latest trends and innovations in AI, integration, and automation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240409873041/en/
Boomi World 2024 User Conference to Feature Deion “Coach Prime” Sanders (Graphic: Business Wire)
Emceed by technology industry veteran and correspondent Lisa Martin, Boomi World 2024 will feature esteemed guest speakers, including:
- Collegiate Head Football Coach and Pro Football Hall of Famer Deion Sanders
- Tropicana CIO Jeff Lischett
- Australian Red Cross CIO Brett Wilson
- Fever-Tree Head of Technology Kate Stables
- KORE Wireless Senior Director of Enterprise Applications Nicki Brock
- OSI Digital CMO Karen Dosanjh
- Gartner Senior Director Analyst John Santoro
- BARC US CEO Shawn Rogers
- IDC Research Director/Analyst Shari Lava
- Boomi CEO Steve Lucas
- Boomi Chief Product and Technology Officer Ed Macosky
- Boomi CTO Matt McLarty; and more!
Boomi World 2024 will provide attendees the opportunity to experience the power of AI-driven connection. Boomi’s customers and partners will discover how Boomi’s intelligent integration and automation platform helps organizations tame IT complexity, drive radical innovation, and synchronize everything, everywhere.
Event Highlights:
1. Robust Agenda
Boomi World 2024 boasts a dynamic and comprehensive agenda, featuring thought-provoking sessions, hands-on workshops, and engaging panel discussions. Attendees will have the opportunity to dive into the latest advancements in integration technology, best practices, and success stories from forward-thinking enterprises across industries that have transformed their organizations with Boomi.
2. Special Guest Deion Sanders
Boomi welcomes Deion Sanders, aka “Coach Prime,” as its special guest speaker.
As head coach from 2020-2022, Sanders led Jackson State University (JSU) to back-to-back SWAC Championships, and won back-to-back SWAC Coach of the Year honors. During his time at JSU, the Tigers had a 27-6 record, including a perfect regular season in 2022. In 2021, he was named the Eddie Robinson Coach of the Year.
Sanders is a member of the Pro Football Hall of Fame, a two-time Super Bowl champion, and eight-time Pro Bowler. He played 14 years in the NFL for the Atlanta Falcons, San Francisco 49ers, Dallas Cowboys, Washington Commanders, and Baltimore Ravens. Sanders is the only person in professional sports history to play in both the World Series and the Super Bowl.
After retiring from professional sports, Sanders became an analyst for CBS Sports and NFL Network, and now offers his insights and opinions on the Pro Football Show on Barstool Sports. He has produced and/or appeared in a variety of television shows, including Tiny House Nation, Grandfathered, Moesha, Running Wild With Bear Grylls, Lip Sync Battle, The League, 30 For 30: Deion’s Double Play, Deion’s Family Playbook, and, most recently, Coach Prime, a docuseries on Prime Video which follows Sanders and his college football journey.
3. Exclusive Announcements
Be the first to hear Boomi's latest product and platform updates, roadmap, and strategic initiatives. Boomi World 2024 will feature exclusive announcements that will shape the future of AI, integration, and automation.
4. Pre-Conference Training and Partner Summit
Starting on May 6, Boomi World will provide optional one and two-day Pre-Conference Training and certification courses, with in-depth sessions covering the various Platform Services within the Boomi platform, including Integration, runtime architecture, API Management, and Master Data Hub.
Taking place on May 7, the Boomi Partner Summit provides partners an exclusive look at the future of the Boomi ecosystem. Partners will get a sneak peek at upcoming announcements and gain access to go-to-market resources designed to drive growth while helping customers more quickly and easily connect, automate, and modernize their digital landscape.
5. 40+ Breakout Sessions
Boomi World will offer more than 40 breakout sessions focused on the following four tracks:
Hands-On Labs will offer attendees the opportunity to explore what’s new in the Boomi platform, get creative with AI, and learn about Retrieval-Augmented Generation — including how to set up a RAG using Boomi.
Developer/Technical track, which will include sessions on popular integration use cases, runtime monitoring, error-handling strategies, master data management, and “Boomi on Boomi” solutions.
CIO/Executive track for executive attendees — or anyone interested in topics designed to appeal to CIOs — which will feature sessions on risk management, Boomi platform security, and AI readiness.
Innovation track, which will include a wide range of sessions from customers, partners, industry analysts, and Boomi technology experts designed to showcase the myriad ways the Boomi platform can be used to connect and transform organizations.
6. Networking Opportunities
Connect with like-minded professionals, industry experts, and Boomi partners during dedicated networking sessions. Boomi World 2024 provides a unique platform to foster collaboration, share ideas, and build valuable relationships within the integration, automation, and connectivity community.
Sponsors:
A special thanks to Boomi’s partner sponsors for helping make Boomi World 2024 possible, including Cognizant and Infosys as Diamond sponsors, and Apica, Kitepipe, LTIMindtree, R Systems, TCS, and United Techno as Platinum sponsors.
Registration:
Registration is now open. Secure your spot at Boomi World 2024 by visiting BoomiWorld.com.
To join the Boomi World conversation on social media, use #BoomiWorld.
Additional Resources
- Learn more about the Boomi platform
- Follow Boomi on LinkedIn, X (Twitter), Facebook, and YouTube
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409873041/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom